- Home
- Publications
- Publication Search
- Publication Details
Title
RNA Therapeutics - Research and Clinical Advancements
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-22
DOI
10.3389/fmolb.2021.710738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
- (2020) Huilin Huang et al. CANCER CELL
- The emerging role of RNA modifications in the regulation of mRNA stability
- (2020) Sung Ho Boo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT).
- (2020) Anna M. Varghese et al. JOURNAL OF CLINICAL ONCOLOGY
- Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19, Virology and Geroscience: A Perspective
- (2020) Camille Vellas et al. Journal of Nutrition Health & Aging
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of MicroRNAs in Bone Metabolism and Disease
- (2020) Yongguang Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2020) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial
- (2020) Vesa Anttila et al. Molecular Therapy-Methods & Clinical Development
- An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- (2019) Imane El Dika et al. ONCOLOGIST
- Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
- (2019) Li-Ming Gan et al. Nature Communications
- Chemical methods for the modification of RNA
- (2019) Marie Flamme et al. METHODS
- Mirror‐Image Oligonucleotides: History and Emerging Applications
- (2019) Brian E. Young et al. CHEMISTRY-A EUROPEAN JOURNAL
- A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
- (2019) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
- (2019) Keith Henry Moss et al. MOLECULAR PHARMACEUTICS
- siRNA therapeutics: a clinical reality
- (2019) Phei Er Saw et al. Science China-Life Sciences
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration.
- (2019) David S. Liao et al. OPHTHALMOLOGY
- RNA Interference Therapy with ARC‐520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection
- (2019) Man‐Fung Yuen et al. HEPATOLOGY
- The Development of Functional Non-Viral Vectors for Gene Delivery
- (2019) Patil et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- N6-Methyladenosine Modification Controls Circular RNA Immunity
- (2019) Y. Grace Chen et al. MOLECULAR CELL
- Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
- (2019) Adachi et al. MOLECULES
- Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
- (2018) Ling Li et al. BIOMATERIALS
- Noncoding RNAs in disease
- (2018) Evangelia Lekka et al. FEBS LETTERS
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maximizing the translational yield of mRNA therapeutics by minimizing 5'-UTRs
- (2018) Zeljka Trepotec et al. TISSUE ENGINEERING PART A
- Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine
- (2018) Leif Carlsson et al. Molecular Therapy-Methods & Clinical Development
- RNA therapeutics for heart disease
- (2018) Federica De Majo et al. BIOCHEMICAL PHARMACOLOGY
- Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
- (2018) Robert A. Jabulowsky et al. CANCER RESEARCH
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- Age-related macular degeneration
- (2018) Paul Mitchell et al. LANCET
- Polo-like kinases and acute leukemia
- (2018) Oksana Goroshchuk et al. ONCOGENE
- La maladie de Willebrand
- (2018) L. Calmette et al. REVUE DE MEDECINE INTERNE
- Modified PAMAM vehicles for effective TRAIL gene delivery to colon adenocarcinoma: in vitro and in vivo evaluation
- (2018) Elham Pishavar et al. Artificial Cells Nanomedicine and Biotechnology
- Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models
- (2018) Kalyan Dulla et al. Molecular Therapy-Nucleic Acids
- Phase I trial of intravenous Ad5CRT in patients with liver metastasis of gastrointestinal cancers
- (2018) Sang-Jin Lee et al. CANCER GENE THERAPY
- Polyethylenimine-based formulations for delivery of oligonucleotides
- (2018) Fei Hao et al. CURRENT MEDICINAL CHEMISTRY
- Modified gelatin nanoparticles for gene delivery
- (2018) Osama Madkhali et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
- (2018) Zeljka Trepotec et al. MOLECULAR THERAPY
- A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy
- (2017) Mingxiang Cai et al. International Journal of Nanomedicine
- Cytomegalovirus Retinitis: A Review
- (2017) Alexander D. Port et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
- (2017) Michael J. Wagner et al. MOLECULAR CANCER THERAPEUTICS
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
- (2017) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Therapeutic effects of protein kinase N3 small interfering RNA and doxorubicin combination therapy on liver and lung metastases
- (2017) Yoshiyuki Hattori et al. Oncology Letters
- Advances in the delivery of RNA therapeutics: from concept to clinical reality
- (2017) James C. Kaczmarek et al. Genome Medicine
- Treatment with QPI-1002, a Short Interfering (SI) RNA for the Prophylaxis of Delayed Graft Function.
- (2017) V. Peddi et al. TRANSPLANTATION
- Osteoblast-Targeting-Peptide Modified Nanoparticle for siRNA/microRNA Delivery
- (2016) Yao Sun et al. ACS Nano
- Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders
- (2016) Daria Wojtal et al. AMERICAN JOURNAL OF HUMAN GENETICS
- What is CRISPR/Cas9?
- (2016) Melody Redman et al. Archives of Disease in Childhood-Education and Practice Edition
- A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.
- (2016) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- siRNA Therapeutics for Primary Hyperoxaluria: A Beginning
- (2016) Dawn S Milliner MOLECULAR THERAPY
- Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
- (2016) Chaitali Dutta et al. MOLECULAR THERAPY
- C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
- (2016) Jan Menne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2016) Glenn J. Jaffe et al. OPHTHALMOLOGY
- From the RNA world to the clinic
- (2016) B. A. Sullenger et al. SCIENCE
- A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts
- (2015) Jin Liu et al. BIOMATERIALS
- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- RNA-targeted Therapeutics for ALS
- (2015) Linga V. Reddy et al. Neurotherapeutics
- Age-Related Macular Degeneration
- (2015) Sonia Mehta PRIMARY CARE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2
- (2015) Dominik Oberthür et al. Nature Communications
- RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
- (2015) Talia Golan et al. Oncotarget
- Abstract 3847: The anti-hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) as treatment of anemia of chronic disease in patients with multiple myeloma, low grade lymphoma, and CLL: A phase II pilot study
- (2015) Pencho Georgiev et al. CANCER RESEARCH
- mRNA transcript therapy
- (2014) Drew Weissman Expert Review of Vaccines
- Genome modification by CRISPR/Cas9
- (2014) Yuanwu Ma et al. FEBS Journal
- Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 andpiggyBac
- (2014) Fei Xie et al. GENOME RESEARCH
- First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors
- (2014) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
- (2014) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection
- (2014) Elisabeth C.R. Solano et al. Nucleic Acid Therapeutics
- Noncoding RNAs in DNA Repair and Genome Integrity
- (2013) Guohui Wan et al. ANTIOXIDANTS & REDOX SIGNALING
- Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
- (2013) Gerald Schwank et al. Cell Stem Cell
- Aptamers: multifunctional molecules for biomedical research
- (2013) Jayeeta Banerjee et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer
- (2012) Phuong Khanh Morrow et al. CANCER
- Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Synthesis of 2′-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus
- (2011) Jolanta Brzezinska et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- The von Willebrand Inhibitor ARC1779 Reduces Cerebral Embolization After Carotid Endarterectomy
- (2011) Hugh S. Markus et al. STROKE
- RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027
- (2010) Peter K. Kaiser et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
- (2010) Teppei Morikawa et al. HUMAN PATHOLOGY
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo
- (2010) Florian B. Mayr et al. TRANSFUSION
- First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder
- (2009) Sancy A Leachman et al. MOLECULAR THERAPY
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
- (2009) Ronald T Mitsuyasu et al. NATURE MEDICINE
- Leber congenital amaurosis: Genes, proteins and disease mechanisms
- (2008) Anneke I. den Hollander et al. PROGRESS IN RETINAL AND EYE RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started